Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/300381 stock hub

SHE/300381 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300381is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.5B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300381

In the news

Latest news · SHE/300381

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/En/a

P25 23.5P50 41.3P75 83.2

ROE-0.2

P25 -0.9P50 4.1P75 8.8

ROIC0.4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300381 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

CNY

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,102
Employees Change	-17%
Employees Change Percent	-1.52
Enterprise value	CNY 3.1B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100001RJ8
Last refreshed	2026-05-10
Market cap	CNY 3.5B
Price	CNY 7.37
Price currency	CNY
Rev Per Employee	764,521.42x
Sector	Healthcare
Sic	2833
Symbol	she/300381
Website	https://vtrbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.23%
EV Earnings	-375.69x
EV/EBITDA	21.57x
EV/FCF	-25.68x
EV/Sales	3.64x
FCF yield	-3.38%
P/B ratio	1.35x
P/S ratio	4.2x
PE Ratio10 Y	152.71x
PE Ratio3 Y	397.08x
PE Ratio5 Y	305.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.07%
EBITDA Margin	16.88%
Gross margin	46.07%
Gross Profit	CNY 388.1M
Gross Profit Growth	6.11%
Gross Profit Growth Q	10.55%
Gross Profit Growth3 Y	6.16%
Gross Profit Growth5 Y	-12.35%
Net Income	CNY -8.2M
Net Income Growth Q	238.47%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-0.38%
Profit Margin	-0.97%
Profit Per Employee	CNY -7,409
ROA	0.2
Roa5y	-0.34
ROCE	0.34
ROE	-0.24
Roe5y	-0.18
ROIC	0.44
Roic5y	-0.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.86%
Cagr1y	0.13%
Cagr3y	-4.92%
Cagr5y	-3.32%
Div CAGR10	0%
Div CAGR3	0%
Div CAGR5	7.39%
EPS Growth Q	239.4
EPS Growth Quarters	1
EPS Growth Years	0
OCF Growth10 Y	19.28%
OCF Growth3 Y	5.19%
OCF Growth5 Y	-18.38%
Revenue Growth	1.54x
Revenue Growth Q	5.06x
Revenue Growth Quarters	2x
Revenue Growth Years	2x
Revenue Growth3 Y	-3.29x
Revenue Growth5 Y	-15.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.29
Assets	CNY 2.9B
Cash	CNY 536M
Current Assets	CNY 1.1B
Current Liabilities	CNY 215.4M
Debt	CNY 18.2M
Debt EBITDA	CNY 0.13
Debt Equity	CNY 0.01
Debt FCF	CNY -0.15
Equity	CNY 2.6B
Liabilities	CNY 266.8M
Long Term Assets	CNY 1.8B
Long Term Liabilities	CNY 51.4M
Net Cash	CNY 517.8M
Net Cash By Market Cap	CNY 14.63
Net Cash Growth	-25.28%
Net Debt EBITDA	CNY -3.64
Net Debt Equity	CNY -0.2
Tangible Book Value	CNY 2.2B
Tangible Book Value Per Share	CNY 4.5
WACC	6.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.91
Inventory Turnover	2.13
Net Working Capital	CNY 323.9M
Quick ratio	3.6
Working Capital	CNY 841.7M
Working Capital Turnover	CNY 0.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.11%
Dividend Growth	66.67%
Dividend Growth Years	1%
Dividend per share	CNY 0.1
Dividend Years	12
Dividend Yield	1.36%
Ex Div Date	2025-07-01
Last Dividend	CNY 0.1
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-55.91%
1Y total return	0.13%
200-day SMA	7
3Y total return	-14.06%
50-day SMA	6.65
50-day SMA vs 200-day SMA	50under200
5Y total return	-15.54%
All Time High	37.28
All Time High Change	-80.23%
All Time High Date	2016-11-03
All Time Low	3.53
All Time Low Change	108.78%
All Time Low Date	2024-02-08
ATR	0.26
Beta	0.34
Beta1y	0.36
Beta2y	0.41
Ch YTD	13.04
High	7.37
High52	8.27
High52 Date	2025-06-09
High52ch	-10.88%
Low	6.89
Low52	5.92
Low52 Date	2026-04-27
Low52ch	24.49%
Ma50ch	10.81%
Price vs 200-day SMA	5.33%
RSI	69.98
RSI Monthly	51.43
RSI Weekly	57.18
Sharpe ratio	-0.11x
Sortino ratio	0.03
Total Return	1.47%
Tr YTD	13.04
Tr1m	14.26%
Tr1w	4.99%
Tr3m	7.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 9M
Operating Income Growth	-30.95
Operating Income Growth Q	158.4
Operating Income Growth5 Y	-48.63
Operating margin	1.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	307,179,705%
Net Borrowing	-17,078,319
Shares Insiders	6.36%
Shares Institutions	2.66%
Shares Out	480,173,861
Shares Qo Q	-0.11%
Shares Yo Y	-0.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY -119.5M
Average Volume	11,552,981.7x
Bv Per Share	5.23
CAPEX	CNY -277.2M
Ch10y	-59.06
Ch1m	14.26
Ch1w	4.99
Ch1y	-1.21
Ch3m	7.59
Ch3y	-17.19
Ch5y	-20.07
Ch6m	3.22
Change	6.2%
Change From Open	6.5
Close	6.94
Days Gap	-0.29
Depreciation Amortization	133,200,795
Dollar Volume	175,764,919
Earnings Date	2026-04-25
EBIT	CNY 9M
EBITDA	CNY 142.2M
EPS	CNY -0.02
F Score	5
FCF	CNY -119.5M
FCF EV Yield	-3.89x
FCF Per Share	CNY -0.25
Financing CF	-65,361,218
Fiscal Year End	December
Founded	1,991
Goodwill	36,673,724
Income Tax	CNY 3M
Investing CF	-172,036,920
Is Primary Listing	1
Last Earnings Date	2026-04-25
Last Report Date	2026-03-31
Last Split Date	2016-10-18
Last Split Type	Forward
Ma150	6.81
Ma150ch	8.29%
Ma20	6.48
Ma20ch	13.72%
Net CF	-82,652,947
Next Earnings Date	2026-08-25
Open	6.92
P OCF Ratio	22.44
Payment Date	2025-07-01
Position In Range	100
Ppne	1,388,617,165
Price Date	2026-05-08
Price EBITDA	CNY 24.88
Ptbv Ratio	1.6
Relative Volume	2.14x
Revenue	842,502,605x
Tax By Revenue	0.36x
Tr6m	3.22%
Volume	23,848,700

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300381 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.4%

$0.10 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+7.4%

1 consecutive years of growth

Total shareholder yield

+1.5%

Next ex-dividend date: 2025-07-01

Performance

SHE/300381 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300381?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.7%

Share of float held by funds and institutions

Insider ownership

+6.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

SHE/300381 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

70.0

Neutral momentum band

Price vs 200-day MA

+5.3%

50/200-day relationship not available

Beta (5Y)

0.34

Less volatile than the market

Sharpe ratio

-0.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300381

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300381 stock rating?

she/300381 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300381 analysis?

The full report lives at /stocks/she/300381/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300381?

The latest report frames she/300381 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300381 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.